Literature DB >> 25368018

Hepatitis D virus coinfection and superinfection.

Francesco Negro1.   

Abstract

HDV is a defective RNA pathogen requiring the simultaneous presence of HBV to complete its life cycle. Two major specific patterns of infection have been described: the coinfection with HDV and HBV of a susceptible, anti-HBs-negative individual, or the HDV superinfection of a chronic HBV carrier. Coinfection mostly leads to the eradication of both agents, whereas the majority of patients with HDV superinfection evolve to chronic HDV infection and hepatitis. Chronic HDV infection worsens the preexisting HBV-related liver damage. HDV-associated chronic liver disease (chronic hepatitis D) is characterized by necroinflammation and the relentless deposition of collagen culminating, within a few decades, into the development of cirrhosis and hepatocellular carcinoma.
Copyright © 2014 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25368018      PMCID: PMC4208707          DOI: 10.1101/cshperspect.a021550

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  60 in total

1.  Establishment of a novel quantitative hepatitis D virus (HDV) RNA assay using the Cobas TaqMan platform to study HDV RNA kinetics.

Authors:  Ingmar Mederacke; Birgit Bremer; Benjamin Heidrich; Janina Kirschner; Katja Deterding; Thomas Bock; Karsten Wursthorn; Michael P Manns; Heiner Wedemeyer
Journal:  J Clin Microbiol       Date:  2010-03-29       Impact factor: 5.948

2.  Quantitative longitudinal evaluations of hepatitis delta virus RNA and hepatitis B virus DNA shows a dynamic, complex replicative profile in chronic hepatitis B and D.

Authors:  Melanie Schaper; Francisco Rodriguez-Frias; Rosendo Jardi; David Tabernero; Maria Homs; Gerardo Ruiz; Josep Quer; Rafael Esteban; Maria Buti
Journal:  J Hepatol       Date:  2010-03-05       Impact factor: 25.083

3.  Genetic changes in hepatitis delta virus from acutely and chronically infected woodchucks.

Authors:  John L Casey; Bud C Tennant; John L Gerin
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

4.  Chronic HDV (hepatitis delta virus) hepatitis. Intrahepatic expression of delta antigen, histologic activity and outcome of liver disease.

Authors:  F Negro; M Baldi; F Bonino; G Rocca; A Demartini; G Passarino; E Maran; C Lavarini; M Rizzetto; G Verme
Journal:  J Hepatol       Date:  1988-02       Impact factor: 25.083

5.  Cytoplasmic tubular structures in liver of HBsAg carrier chimpanzees infected with delta agent and comparison with cytoplasmic structures in non-A, non-B hepatitis.

Authors:  T Kamimura; A Ponzetto; F Bonino; S M Feinstone; J L Gerin; R H Purcell
Journal:  Hepatology       Date:  1983 Sep-Oct       Impact factor: 17.425

6.  Direct evidence for cytotoxicity associated with expression of hepatitis delta virus antigen.

Authors:  S M Cole; E J Gowans; T B Macnaughton; P D Hall; C J Burrell
Journal:  Hepatology       Date:  1991-05       Impact factor: 17.425

7.  Patterns of hepatitis delta virus reinfection and disease in liver transplantation.

Authors:  A Ottobrelli; A Marzano; A Smedile; S Recchia; M Salizzoni; C Cornu; M E Lamy; J B Otte; B De Hemptinne; A Geubel
Journal:  Gastroenterology       Date:  1991-12       Impact factor: 22.682

8.  Hepatitis delta virus inhibits alpha interferon signaling.

Authors:  Paolo Pugnale; Valerio Pazienza; Kévin Guilloux; Francesco Negro
Journal:  Hepatology       Date:  2009-02       Impact factor: 17.425

9.  Rapidly progressive HBsAg-positive hepatitis in Italy. The role of hepatitis delta virus infection.

Authors:  G Saracco; F Rosina; M R Brunetto; P Amoroso; F Caredda; P Farci; P Piantino; F Bonino; M Rizzetto
Journal:  J Hepatol       Date:  1987-12       Impact factor: 25.083

10.  Genotyping of hepatitis D virus by restriction-fragment length polymorphism and relation to outcome of hepatitis D.

Authors:  J C Wu; K B Choo; C M Chen; T Z Chen; T I Huo; S D Lee
Journal:  Lancet       Date:  1995-10-07       Impact factor: 79.321

View more
  26 in total

Review 1.  Epidemiology, Natural History, and Treatment of Hepatitis Delta Virus Infection in HIV/Hepatitis B Virus Coinfection.

Authors:  Nicole D Ferrante; Vincent Lo Re
Journal:  Curr HIV/AIDS Rep       Date:  2020-08       Impact factor: 5.071

Review 2.  Hepatitis delta virus: insights into a peculiar pathogen and novel treatment options.

Authors:  Florian A Lempp; Yi Ni; Stephan Urban
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-08-18       Impact factor: 46.802

3.  Impact of nucleic acid extraction platforms on hepatitis virus genome detection.

Authors:  Matthew D Pauly; Saleem Kamili; Tonya M Hayden
Journal:  J Virol Methods       Date:  2019-08-13       Impact factor: 2.014

4.  Hepatitis D infection: from initial discovery to current investigational therapies.

Authors:  Ben L Da; Theo Heller; Christopher Koh
Journal:  Gastroenterol Rep (Oxf)       Date:  2019-06-23

5.  Hepatitis B, C, and D Virus Infections and AFP Tumor Marker Prevalence Among the Elderly Population in Mongolia: A Nationwide Survey.

Authors:  Davaalkham Dambadarjaa; Yerkyebulan Mukhtar; Enkh-Oyun Tsogzolbaatar; Ser-Od Khuyag; Angarmurun Dayan; Nandin-Erdene Oyunbileg; Oyu-Erdene Shagdarsuren; Gunchmaa Nyam; Yosikazu Nakamura; Masaharu Takahashi; Hiroaki Okamoto
Journal:  J Prev Med Public Health       Date:  2022-05-20

Review 6.  Viral hepatitis vaccination during pregnancy.

Authors:  Yueyuan Zhao; Hui Jin; Xuefeng Zhang; Bei Wang; Pei Liu
Journal:  Hum Vaccin Immunother       Date:  2016-04-02       Impact factor: 3.452

7.  Interferon signaling suppresses the unfolded protein response and induces cell death in hepatocytes accumulating hepatitis B surface antigen.

Authors:  Ian Baudi; Masanori Isogawa; Federica Moalli; Masaya Onishi; Keigo Kawashima; Yuji Ishida; Chise Tateno; Yusuke Sato; Hideyoshi Harashima; Hiroyasu Ito; Tetsuya Ishikawa; Takaji Wakita; Matteo Iannacone; Yasuhito Tanaka
Journal:  PLoS Pathog       Date:  2021-05-12       Impact factor: 6.823

8.  Vibration-controlled transient elastography for the detection of cirrhosis in chronic hepatitis D infection.

Authors:  Ben L Da; Pallavi Surana; Varun Takyar; David E Kleiner; Theo Heller; Christopher Koh
Journal:  J Viral Hepat       Date:  2019-12-09       Impact factor: 3.517

Review 9.  Reactivation of hepatitis B after liver transplantation: Current knowledge, molecular mechanisms and implications in management.

Authors:  Ranjit Chauhan; Shilpa Lingala; Chiranjeevi Gadiparthi; Nivedita Lahiri; Smruti R Mohanty; Jian Wu; Tomasz I Michalak; Sanjaya K Satapathy
Journal:  World J Hepatol       Date:  2018-03-27

10.  Discontinuation of Passive Immunization Is Safe after Liver Transplantation for Combined HBV/HDV Infection.

Authors:  Ramin Raul Ossami Saidy; Irina Sud; Franziska Eurich; Mustafa Aydin; Maximilian Paul Postel; Eva Maria Dobrindt; Johann Pratschke; Dennis Eurich
Journal:  Viruses       Date:  2021-05-13       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.